Tranzyme Enters Strategic Drug Discovery Collaboration With BMS

Tranzyme Pharma Tuesday announced that it has entered into a strategic collaboration agreement with Bristol-Myers Squibb Company to discover, develop and commercialize novel macrocyclic compounds directed against targets of interest to Bristol-Myers Squibb.
Earth Times